ABOUT

About MyPepInfo

Independent educational reference for clinical peptide research.

MyPepInfo is an independent educational reference resource on peptide research, intended for licensed clinicians, researchers, and the curious public. We do not sell products, dispense medical advice, or operate as a healthcare provider.

Mission

To provide clear, well-cited reference material on peptide protocols and individual peptide monographs, organized for clinicians making evidence-based decisions and for researchers tracking the published literature.

Editorial standards

• Reviewed by licensed professionals. Clinical content is reviewed by a licensed medical reviewer prior to publication.
• Citations. Every clinical or mechanistic claim is intended to be backed by a peer-reviewed citation, or explicitly flagged as preclinical or theoretical.
• No marketing. Pages do not promote any specific product, brand, or supplier.
• Hedged claims. Where the literature is sparse, contested, or evolving, we say so plainly rather than overstating certainty.
• Periodic review. Content is reviewed quarterly. Each page carries a “Last reviewed” date.

Independence and conflicts of interest

MyPepInfo is independent. The Site is not affiliated with, sponsored by, or owned by any peptide manufacturer, distributor, compounding pharmacy, or clinic. The Site does not run advertising and does not accept paid placements. If this changes in the future, the change will be disclosed here.

What MyPepInfo is not

• Not a medical advisory service. Information here does not replace consultation with a licensed clinician.
• Not a pharmacy. We do not compound, sell, or ship peptides or any other compound.
• Not a regulator. Statements have not been evaluated by the U.S. Food and Drug Administration. See our Terms & Conditions for the full disclaimer.
• Not a clinical trial registry. We summarize and link to published findings; we do not run trials.

Contact

Editorial corrections, citation requests, partnership inquiries, and general feedback: [email protected]. Replies typically within one to two business days. See also our contact page.

Last reviewed: May 5, 2026.